• Molecular NameSulfacetamide
  • SynonymNA
  • Weight214.245
  • Drugbank_IDDB00634
  • ACS_NO144-80-9
  • Show 3D model
  • LogP (experiment)-1.0
  • LogP (predicted, AB/LogP v2.0)-0.52
  • pka1.8, 5.4
  • LogD (pH=7, predicted)-2.24
  • Solubility (experiment)6.62 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)0.12
  • LogSw (predicted, AB/LogsW2.0)6.77
  • Sw (mg/ml) (predicted, ACD/Labs)15.19
  • No.of HBond Donors3
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds2
  • TPSA97.64
  • StatusFDA approved
  • AdministrationN/A
  • PharmacologyA sulfonamide antibiotic.
  • Absorption_valueN/A
  • Absorption (description)N/A
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding82.5
  • Volume of distribution (VD)N/A
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmN/A
  • Half life2.5 h
  • ExcretionN/A
  • Urinary ExcretionN/A
  • CleranceN/A
  • ToxicitySide effects include moderate to severe erythema (redness) and moderate edema (raised kin), nausea, vomiting, headache, dizziness, and tiredness. Higher exposure causes unconsciousness.
  • LD50 (rat)N/A
  • LD50 (mouse)LD50=16500 mg/kg